
My Next Health (MNH) is a healthcare company employing a genomic-based AI and quantum platform to advance clinical trials, point-of-care solutions, and personalized consumer health. Their proprietary approach focuses on the intricate interactions between genes and epigenetic factors (environment, lifestyle, nutrition) that influence metabolic pathways. With insights derived from over 15,000 case studies, MNH is leveraging a generative AI platform and exponential technologies like quantum computing to revolutionize drug discovery, development, and personalized healthcare applications. The company is based in New York, NY.

My Next Health (MNH) is a healthcare company employing a genomic-based AI and quantum platform to advance clinical trials, point-of-care solutions, and personalized consumer health. Their proprietary approach focuses on the intricate interactions between genes and epigenetic factors (environment, lifestyle, nutrition) that influence metabolic pathways. With insights derived from over 15,000 case studies, MNH is leveraging a generative AI platform and exponential technologies like quantum computing to revolutionize drug discovery, development, and personalized healthcare applications. The company is based in New York, NY.